Human medicines European public assessment report (EPAR): Memantine Merz, memantine hydrochloride, Date of authorisation: 22/11/2012, Revision: 9, Status: Authorised

Human medicines European public assessment report (EPAR): Memantine Merz, memantine hydrochloride, Date of authorisation: 22/11/2012, Revision: 9, Status: Authorised

Human medicines European public assessment report (EPAR): Yorvipath, palopegteriparatide, Date of authorisation: 17/11/2023, Revision: 5, Status: Authorised

Human medicines European public assessment report (EPAR): Yorvipath, palopegteriparatide, Date of authorisation: 17/11/2023, Revision: 5, Status: Authorised

Human medicines European public assessment report (EPAR): Axura, memantine, Date of authorisation: 17/05/2002, Revision: 29, Status: Authorised

Human medicines European public assessment report (EPAR): Axura, memantine, Date of authorisation: 17/05/2002, Revision: 29, Status: Authorised

Virtual live hands-on training course for clinical trials sponsors using EudraVigilance system - December 2025, Online, European Medicines Agency, Amsterdam, the Netherlands, from 8 December 2025, 09:00 (CET) to 10 December 2025, 13:00 (CET)

Virtual live hands-on training course for clinical trials sponsors using EudraVigilance system - December 2025, Online, European Medicines Agency, Amsterdam, the Netherlands, from 8 December 2025, 09:00 (CET) to 10 December 2025, 13:00 (CET)

Virtual live hands-on training course for clinical trials sponsors using EudraVigilance system - October 2025, Online, European Medicines Agency, Amsterdam, the Netherlands, from 1 October 2025, 14:00 (CEST) to 3 October 2025, 18:00 (CEST)

Virtual live hands-on training course for clinical trials sponsors using EudraVigilance system - October 2025, Online, European Medicines Agency, Amsterdam, the Netherlands, from 1 October 2025, 14:00 (CEST) to 3 October 2025, 18:00 (CEST)

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

randomness